DETAILS, FICTION AND SR 17018 FOR SALE

“The compound SR-17018 is the first biased agonist in the mu opioid receptor that does not result in tolerance with chronic use,” says Stahl, a senior workers scientist while in the Bohn lab. “This is the attractive aspect for probable use from the context of Continual, serious pain.”Wow I didn’t understand that thanks with the heads up!